共 50 条
- [34] Establishing Upper GI Toxicity Remission With Vedolizumab Maintenance Therapy While Resuming Immune Checkpoint Inhibitor AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1290 - S1291
- [35] Rheumatic Immune-Related Adverse Events-A Consequence of Immune Checkpoint Inhibitor Therapy BIOLOGY-BASEL, 2021, 10 (06):
- [37] Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction Current Heart Failure Reports, 2024, 21 : 214 - 223
- [40] Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy JCO CLINICAL CANCER INFORMATICS, 2024, 8